Relevance of Intellectual

Intellectual Property is like any other property and the developed countries respect and comply with Intellectual Property India has to do the same. Historically, India was the seat of knowledge and wisdom, and India was the leader in most disciplines. Nalanda and Takshila were the seats of wisdom...
   More Details... 



 WHO-GMP Approved
 manufacturing facilities

WHO-GMP Approved manufacturing facilities for Oncology (Mumbai), General tablets and cephalosporin (Uttaranchal near Delhi) 


Klab GlobalPartners Licenses Unique Life Science Products.  


  • Klab identifies Companies which have unique high performance Life Science products(with complete scientific back up data/trials etc) which are already marketed in the developed countries like USA,UK etc. These companies do not have any marketing presence in India.
  • These products are such that Klab can get fast track FDA approval in India without clinical trials.Example-Medical devices, cosmetic/OTC/Herbal etc products.
  • Klab reaches exclusive arrangements for the Indian Market.
  • Klab builds a relationship of trust with the key decision makers as also ensures a fast & efficient implementation loop.
  • Klab provides detailed turnkey reports on the Indian Market/Competition/Entry Strategy/FDA Approvals etc to ensure well informed holistic decisionmaking.
  • Klab out licenses products to companies in india who successfully launch several new products every year.
  • Klab gets involved with the complete new products long term strategy as also grass root implementation to ensure turnkey commercialisation.
  • Connexicon Medical Ltd.-Connexicon is an Irish company that specialises in the manufacture of Tissue Adhesives and Sealants for Topical and Internal applications. KLAB has reached an agreement for the exclusive rights for Indermil Fuse (skin adhesive device) for the Indian market.
  • Innovus-Innovus Pharma is a US based company focusing on the commercialization of over-the-counter (“OTC”) and consumer products for men’s and women’s health, vitality and respiratory diseases.Innovus has reached an exclusive agreement with Klab to market Zestra,EjectDelay,Sensum & Zestra Glide in the Indian Sub Continent.
  • Orthogem-Orthogem is a UK based biomaterials company. Klab Has reached an Exclusive arrangement with Orthogem to market Tripore in India.Tripore is a new generation advanced Synthetic Bone Graft.
  • IFC-Is a Spanish Group dedicated to the field of Dermatological & Nutritional Science. Klab Has reached an Exclusive arrangement with IFC to market Radiocare in India.
  • Opko Health Spain-Is a part of Opko Health which is owned by Phillip Frost. Klab Has reached an Exclusive arrangement with pro Health Spain to market Isrene Gel & Pelvic Gel in India.

Hydroxyurea,Imatinib,Letrozole,Methotrexate,Tamoxifen & Zoledronic .

Irinotecan,Oxaliplatin,Paclitaxel, Pemetrexed,Temozolomide & Vincristine.

Camylofin Dihydrochloride, Doxapram Hydrochloride, Glycopyrrolate, Isocarboxazid, Leflunomide, Modafinil, Otilonium bromide.

Klab is having formulation & API dossiers available both in CTD as well as country specific formats.The API documents available are equivalent to CTD(Europe),DMF(US) standards subject to site approval. KLAB has got WHO GMP/cGMP/ISO14001/ISO9001/GLP certifications

Intellectual Property

 Nano Silver Gel - KLAB has received Drugs Controller General of India approval for its Nano silver gel for manufacturing and marketing in India for burns,cuts and wounds. Klab has also got a product patent granted for India..
KLAB has given Hetero non exclusive marketing rights for India.

KLAB has been granted a product & process patent for the following products:
Cefixime+Cloxacillin+Lactobacillus, Cefixime O.D.& Cefixime with Flavinoid.KLAB has a patent pending with Dicloxacillin.KLAB also has patents for these combinations internationally.
Methocarbamol (Skeletal Muscle Relaxant)
- Methocarbamol with Nimesulide tablet, Diclofenac tablet, Nimsulide dispersible tablet and Diclofenac gel.
Prenoxidiazine Tablet (Anti tussive).
Glycopyrrolate tablets.
Etoricoxib and Paracetamol tablets.
Methotrexate Gel.

KLAB is manufacturing formulations since 1945
KLAB’s Oncology formulations and factory (Mumbai) are registered in-
Zambia, Kenya, Nigeria, Niger, Malawi, Mali, Burkina Faso, Thailand, Myanmar, Philippines, Srilanka, Bhutan, Iran & Pakistan .
Registrations are pending in - Bahamas, Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Jamaica, Nicaragua, Panama, Paraguay, Peru, Trinidad & Tobago, Uruguay, Venezuela more...

KLAB’s general oral products facility (Uttaranchal, near .Delhi) is registered in Mongolia, Hong Kong, Bhutan, Srilanka, Cambodia, Vietnam, Philippines, Myanmar, Thailand, Honduras, Mozambique, Nigeria & Kenya. more...

KLAB is supplying Onco API’s to Indonesia, Canada, Bangladesh, Switzerland, Pakistan, Australia,New Zealand, Turkey, Germany, Korea, Cyprus & Denmark . more...

KLAB is manufacturing Oncology formulations for M/S Ranbaxy, M/S Biochem (Zydus), M/S Hetero, M/S Glenmark , M/s Cadila , M/s Wockhardt , M/S Emcure  & M/S Zuventis, etc.. . 

Marketing Infrastructure in India
Klab's 350 Medical Representatives,80 managers meet 90,000 Doctors and 50000 Pharmacies every month, with special focus on Gastroenterologists, General Surgeons, Gynaecologists, Orthopedic Surgeons, Pediatricians and Physicians. more..

KLAB’s 24 Oncology Executives (EOB’s) meet all the Medical Oncologists, Haemato-Oncologists, Radiation Oncologists & Surgical Oncologists in India. They also meet all the Institutions & Government Departments for the Oncology tender business.

KLab has developed multifunctional Chiral Pools of Carbohydrates, Monosaccharides, Amino Alcohols, Oxazolidinones etc
KLab is developing an economical dendrimer system for cosmetic applications and drug delivery.
 KLab has filed for several patents using dendrimers as a delivery platform.

KLab has filed several patents for site specific deliveries



Current Openings

  © 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.